GFAP and S100 are important biomarkers of astrocytes, often showing elevated expression in many neurodegenerative diseases such as PD, AD, multiple system atrophy, and dementia with Lewy bodies (Schulz et al., 2021). This evidence concerns the gene GFAP and multiple system atrophy.